2018 – 2019 Regenerative Medicine Seed Grant Announcement
Deadline: July 9, 2018
Call for “Georgia Partners in Regenerative Medicine” Seed Grant Program
The University of Georgia, Georgia Institute of Technology, and Emory University under the Regenerative Engineering and Medicine Center (REM) announce the 2018-19 “Georgia Partners in Regenerative Medicine” seed grant program.
This funding mechanism is intended to stimulate new, collaborative research in regenerative medicine among Georgia Tech, Emory University and UGA investigators. The seed grant team must have a minimum of two investigators and must have an equal partnership of faculty from two of the participating institutions with budgets split between the universities as equally as possible.
This funding mechanism may support collaborative projects at earlier stages of development in the “high risk, high yield” category or projects with a high potential for clinical or industry translation. Budgets for these proposals may not exceed $50,000.
Deadline: The deadline for submission of proposals is July 9, 2018. Awards will be announced in mid-August.
All faculty members with primary appointments at Emory University, Georgia Institute of Technology, and University of Georgia are eligible to apply.
Proposals from those addressing new questions or taking new approaches are encouraged.
Teams must consist of UGA and Emory, UGA and Georgia Tech, or Georgia Tech and Emory investigators.
Investigators may not receive regenerative medicine seed grant funding for more than 3 years out of any 5 year period.
The funding timeline for each award will be dependent on the type of funds used and the institution they are coming from. Details will be outlined in official award letters.
Funds may be used for Ph.D. student/postdoc support, animal studies, research materials and supplies, and limited travel as related to the conduct of the research. Faculty salary support is not appropriate.
Applicants are reminded that these are seed grants that are intended to promote the acquisition of extramural funding.
The Regenerative Engineering and Medicine Center should be recognized in any grant or publication acknowledgements.
The application must include a description of the long term funding strategy.
Failure to submit a timely progress by Monday, April 1, 2019 report will result in ineligibility for future award opportunities from this seed grant program.
**Emory Exception – IF TEAM INCLUDES P.I. FROM EMORY
The success of the research grant program will be measured by the publications and follow-on extramural funding from the seed grant and generation of intellectual property, and/or the initiation of clinical studies. Publications arising from a Emory / UGA or Georgia Tech / Emory seed grant should include the following citation in any publication, press release, or other document resulting from direct or indirect ACTSI support, “Supported by the National Center for Advancing Translational Sciences of the National Institutes of Health under Award Number UL1TR00454. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.”
* Please note that no clinical trial activity beyond phase IIA may be supported by this grant. For more information on the definition of clinical trials and phases, please refer to the NIH Grants Policy Statement at https://sitegrants.nih.gov/grants/policy/nihgps_2013/. For all allowable clinical trials the grantee must register the clinical trial on the ClinicalTrials.gov Protocol Registration System Information Website at https://register.clinicaltrials.gov.
**Georgia Tech and UGA Exception
For Georgia Tech and UGA students supported on these funds, their tuition will be waived.
Prior recipients of seed grant funding must fill out a progress report of work completed under the prior funding. This will be collected on an on-line system and should include a summary of the work, publications and presentations and funding applied for and/or received. If extramural grant applications were unsuccessful, reviews and scores from those applications should be included.
The format for these grants is the same as used by the NIH for standard R01 applications with the exception that there is a 3 page limit to the application (excluding budget, abstract and references).
Applications should include the proposal, a detailed budget using NIH forms and 2 page biosketches for the investigators.